EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies

Heather Wilson-Robles iD, Emma Warry, Tasha Miller, Jill Jarvis, Matthew Matsushita, Pamela Miller, Marielle Herzog, Jean-Valery Turatsinze, Theresa K Kelly, S Thomas Butera, Gaetan Michel

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Heather Wilson-Robles und 10 weiteren Autor:innen. Beteiligte Einrichtung: Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America. Hauptthemen laut MEDLINE: Neoplasms, Hematologic Neoplasms, Dog Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hematopoietic malignancies are extremely common in pet dogs and represent nearly 30% of the malignancies diagnosed in this population each year. Clinicians commonly use existing tools such as physical exam findings, radiographs, ultrasound and baseline blood work to monitor these patients for treatment response and remission. Circulating biomarkers, such as prostate specific antigen or carcinoembryonic antigen, can be useful tools for monitoring treatment response and remission status in human cancer patients. To date, there has a been a lack of useful circulating biomarkers available to veterinary oncology patients.

Methods

Circulating plasma nucleosome concentrations were evaluated at diagnosis, throughout treatment and during remission monitoring for 40 dogs with lymphoma, acute myelogenous leukemia and multiple myeloma. Additionally, C-reactive protein and thymidine kinase-1 levels were recorded.

Results

Plasma nucleosome concentrations were significantly higher at diagnosis and progressive disease than they were when dogs were in remission. All but two dogs had plasma nucleosome concentrations that returned to the low range during treatment. These two dogs had the shortest progression free and overall survival times. Dogs with the highest plasma nucleosome concentrations had a significantly shorter first progression free survival than dogs with lower plasma nucleosome concentrations at diagnosis. Plasma nucleosome concentrations correlated better with disease response and progression than either thymidine kinase or C reactive protein.

Conclusions

Plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHematologic NeoplasmsDog DiseasesMaleHumansDogsAnimalsNucleosomesThymidine KinaseBiomarkersC-Reactive Protein

Substanzen

NucleosomesThymidine KinaseBiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Small Animal Clinical Sciences Department, Texas A&M University, College Station, Texas, United States of America.
  • Volition Veterinary Diagnostics Development, Henderson, Nevada, United States of America.
  • Belgian Volition SRL, Parc Scientifique Crealys, Isnes, Belgium.
  • Volition America LLC, Henderson, Nevada, United States of America.

ORCID-Profile: Heather Wilson-Robles

Zitieren

APA

Wilson-Robles, H., Warry, E., Miller, T., Jarvis, J., Matsushita, M., Miller, P., Herzog, M., Turatsinze, J. V., Kelly, T. K., Butera, S. T., & Michel, G. (2023). Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies. PLOS ONE. https://doi.org/10.1371/journal.pone.0281796

Vancouver

Wilson-Robles H, Warry E, Miller T, Jarvis J, Matsushita M, Miller P, et al. Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies. PLOS ONE. 2023. doi:10.1371/journal.pone.0281796

BibTeX
@article{WilsonRobles2023,
  author = {Wilson-Robles, Heather and Warry, Emma and Miller, Tasha and Jarvis, Jill and Matsushita, Matthew and Miller, Pamela and Herzog, Marielle and Turatsinze, Jean-Valery and Kelly, Theresa K and Butera, S Thomas and Michel, Gaetan},
  title = {Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281796}
}
Kostenlos starten →